Patch testing with hydroxyisohexyl 3‐cyclohexene carboxaldehyde (HICC) – a multicentre study of the Swedish Contact Dermatitis Research Group

Summary Background In 2014, the fragrance hydroxyisohexyl 3‐cyclohexene carboxaldehyde (HICC) was excluded from the Swedish baseline series. Objectives To study (i) whether fragrance mix (FM) II with 5% HICC detects more positive reactions than usual FM II with 2.5% HICC, and (ii) the reproducibilit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Contact dermatitis 2017-01, Vol.76 (1), p.34-39
Hauptverfasser: Engfeldt, Malin, Hagvall, Lina, Isaksson, Marléne, Matura, Mihály, Mowitz, Martin, Ryberg, Kristina, Stenberg, Berndt, Svedman, Cecilia, Bruze, Magnus
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background In 2014, the fragrance hydroxyisohexyl 3‐cyclohexene carboxaldehyde (HICC) was excluded from the Swedish baseline series. Objectives To study (i) whether fragrance mix (FM) II with 5% HICC detects more positive reactions than usual FM II with 2.5% HICC, and (ii) the reproducibility of patch testing with HICC. Methods Two thousand one hundred and eighteen dermatitis patients at five Swedish dermatology departments were consecutively tested with FM II 14% pet., FM II 16.5% pet., and duplicate preparations of HICC 5% pet. Results Of the patients, 3.2% reacted to FM II 14%, and 1.5% reacted to HICC. Separate testing with HICC detected 0.3% reactions without concomitant reactivity to FM II. FM II with 5% HICC did not give rise to more irritant reactions or signs of active sensitization than FM II with 2.5% HICC. Patch testing with duplicate applications of HICC increased the overall prevalence of HICC contact allergy to 1.9%. Conclusion FM II with 5% HICC does not detect more positive reactions than FM II with 2.5% HICC. Separate testing with HICC does not detect a sufficient proportion of patients who react only to HICC, without concomitant reactions to FM II, to warrant its inclusion in a baseline series.
ISSN:0105-1873
1600-0536
1600-0536
DOI:10.1111/cod.12699